SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
-0.7%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$12.9B
AUM Growth
+$187M
(+1.5%)
Cap. Flow
+$430M
Cap. Flow
% of AUM
3.33%
Top 10 Holdings %
Top 10 Hldgs %
20.89%
Holding
2,455
New
620
Increased
592
Reduced
680
Closed
495
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
iShares MSCI India ETF
INDA
|
+$132M |
| 3 |
Apple
AAPL
|
+$79.6M |
| 4 |
C.H. Robinson
CHRW
|
+$78.4M |
| 5 |
CSX Corp
CSX
|
+$72.7M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$783M |
| 2 |
United Airlines
UAL
|
+$84.8M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$77.2M |
| 4 |
FedEx
FDX
|
+$71.5M |
| 5 |
Amazon
AMZN
|
+$70M |
Sector Composition
| 1 | Industrials | 17.28% |
| 2 | Technology | 14.28% |
| 3 | Consumer Discretionary | 10.33% |
| 4 | Healthcare | 8.43% |
| 5 | Financials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Neurocrine Biosciences
NBIX
$14.1B
| $4.19M | 0.03% |
30,413
-17,281
| -36% | -$2.38M |
|
527
Intellia Therapeutics
NTLA
$1.25B
| $4.17M | 0.03% |
186,440
+160,719
| +625% | +$3.6M |
|
528
UroGen Pharma
URGN
$899M
| $4.17M | 0.03% |
248,399
+144,299
| +139% | +$2.42M |
|
529
APi Group
APG
$14.7B
| $4.15M | 0.03% |
+165,588
| New | +$4.15M |
|
530
Jefferies Financial Group
JEF
$13.5B
| $4.15M | 0.03% |
83,422
-85,422
| -51% | -$4.25M |
|
531
Enbridge
ENB
$106B
| $4.15M | 0.03% |
116,500
+90,000
| +340% | +$3.2M |
|
532
InterContinental Hotels
IHG
$18.7B
| $4.12M | 0.03% |
38,900
+17,178
| +79% | +$1.82M |
|
533
Rio Tinto
RIO
$101B
| $4.12M | 0.03% |
62,500
+38,300
| +158% | +$2.53M |
|
534
New Oriental
EDU
$8.88B
| $4.09M | 0.03% |
52,665
-7,601
| -13% | -$591K |
|
|
HES
535
DELISTED
Hess
HES
| $4.07M | 0.03% |
27,580
+20,910
| +313% | +$3.08M |
|
536
Dyne Therapeutics
DYN
$1.86B
| $4.07M | 0.03% |
115,195
-154,562
| -57% | -$5.45M |
|
537
HCA Healthcare
HCA
$92.6B
| $4.04M | 0.03% |
12,562
-13,186
| -51% | -$4.24M |
|
538
NVR
NVR
$22.9B
| $4.01M | 0.03% |
528
-599
| -53% | -$4.55M |
|
539
Hancock Whitney
HWC
$5.37B
| $4.01M | 0.03% |
83,742
-49,613
| -37% | -$2.37M |
|
540
Impinj
PI
$5.63B
| $4M | 0.03% |
25,513
-73,594
| -74% | -$11.5M |
|
541
AppFolio
APPF
$9.99B
| $3.99M | 0.03% |
+16,330
| New | +$3.99M |
|
542
Annexon
ANNX
$260M
| $3.99M | 0.03% |
814,221
+52,621
| +7% | +$258K |
|
|
JNPR
543
DELISTED
Juniper Networks
JNPR
| $3.97M | 0.03% |
108,980
+91,760
| +533% | +$3.35M |
|
544
BHP
BHP
$135B
| $3.97M | 0.03% |
69,500
-8,400
| -11% | -$480K |
|
545
Vanguard Mortgage-Backed Securities ETF
VMBS
$14.9B
| $3.97M | 0.03% |
+87,387
| New | +$3.97M |
|
546
Essent Group
ESNT
$6.26B
| $3.96M | 0.03% |
70,537
-49,063
| -41% | -$2.76M |
|
547
Eledon Pharmaceuticals
ELDN
$159M
| $3.96M | 0.03% |
1,500,000
+1,449,200
| +2,853% | +$3.83M |
|
|
CDMO
548
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $3.96M | 0.03% |
553,953
+53,451
| +11% | +$382K |
|
549
Roper Technologies
ROP
$55.2B
| $3.95M | 0.03% |
7,000
+6,280
| +872% | +$3.54M |
|
550
Iron Mountain
IRM
$28.8B
| $3.94M | 0.03% |
44,009
-71,852
| -62% | -$6.44M |
|